A Call for Objective Dose Selection to Increase Success in Pediatric Clinical Trials: A Perspective From NICHD and NIMH Program Staff.
作者信息
Giacoia George, Grabb Margaret C, Pawlyk Aaron C, Ren Zhaoxia, Samedy-Bates Lesly, Taylor-Zapata Perdita
机构信息
Obstetric and Pediatric Pharmacology and Therapeutics Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Bethesda, Maryland, USA.
National Institute of Mental Health (NIMH), Bethesda, Maryland, USA.
出版信息
J Clin Pharmacol. 2021 Jun;61 Suppl 1:S9-S12. doi: 10.1002/jcph.1849.
PMID:34185908
Abstract
摘要
相似文献
1
A Call for Objective Dose Selection to Increase Success in Pediatric Clinical Trials: A Perspective From NICHD and NIMH Program Staff.呼吁进行客观剂量选择以提高儿科临床试验成功率：来自美国国立儿童健康与人类发展研究所和美国国立精神卫生研究所项目工作人员的观点
J Clin Pharmacol. 2021 Jun;61 Suppl 1:S9-S12. doi: 10.1002/jcph.1849.
2
Progress in Drug Development-Pediatric Dose Selection: Workshop Summary.药物研发进展-儿科剂量选择：研讨会总结。
J Clin Pharmacol. 2021 Jun;61 Suppl 1:S13-S21. doi: 10.1002/jcph.1828.
3
The European Medicines Agency Experience With Pediatric Dose Selection.欧洲药品管理局在儿科剂量选择方面的经验。
J Clin Pharmacol. 2021 Jun;61 Suppl 1:S22-S27. doi: 10.1002/jcph.1863.
4
Model-Informed Pediatric Drug Development: Application of Pharmacometrics to Define the Right Dose for Children.模型指导下的儿科药物研发：药物代谢动力学在确定儿童适宜剂量中的应用。
J Clin Pharmacol. 2021 Jun;61 Suppl 1:S52-S59. doi: 10.1002/jcph.1841.
5
Methods Used for Pediatric Dose Selection in Drug Development Programs Submitted to the US FDA 2012-2020.2012-2020 年向美国 FDA 提交的药物开发计划中儿科剂量选择方法。
J Clin Pharmacol. 2021 Jun;61 Suppl 1:S28-S35. doi: 10.1002/jcph.1853.
6
Real-World Data for Pediatric Pharmacometrics: Can We Upcycle Clinical Data for Research Use?儿科药物计量学的真实世界数据：我们能否将临床数据升级用于研究？
Clin Pharmacol Ther. 2019 Jul;106(1):84-86. doi: 10.1002/cpt.1416. Epub 2019 Apr 3.
7
Model-Informed Drug Development: A Regulatory Perspective on Progress.模型引导的药物研发：监管视角下的进展
Clin Pharmacol Ther. 2019 Jul;106(1):91-93. doi: 10.1002/cpt.1475. Epub 2019 Jun 4.
8
Minors and a Dawning Paradigm Shift in "Pediatric" Drug Development.未成年人与“儿科”药物研发中初现的范式转变
J Clin Pharmacol. 2021 Jun;61(6):736-739. doi: 10.1002/jcph.1806. Epub 2021 Jan 12.
9
Adolescents and Drug Development: Commentary on a Dawning Paradigm Shift.青少年与药物研发：对一场初现端倪的范式转变的评论
J Clin Pharmacol. 2021 Jun;61(6):740-743. doi: 10.1002/jcph.1862. Epub 2021 Apr 20.
10
Neonatal and Pediatric Dose Selection: Quo Vadis?新生儿和儿科剂量选择：何去何从？
J Clin Pharmacol. 2021 Jun;61 Suppl 1:S7-S8. doi: 10.1002/jcph.1888.
Zotero 插件